COMMUNIQUÉS West-GlobeNewswire

Vystar Completes Acquisition of R3ALM Financial Ecosystem, Targets $120 Million Tokenized Equity Launch
10/08/2026
■ ■ ■ Consideration includes approximately 8,371 shares of Vystar Series B preferred stock Parties intend to jointly manage and develop the R3alm platform R3alm is being developed as a compliance-focused ecosystem [...]
Silo Pharma Granted European Patent Covering Novel PTSD Therapy
10/08/2026
Patent strengthens global IP protection for novel treatment approach designed to prevent stress-induced psychiatric disorders before symptoms develop SARASOTA, FLA., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq [...]
Hemp Hop THCa Dispensary Extends Pickup and Charlotte Same Day Delivery Hours to 11 PM Daily
10/08/2026
CHARLOTTE, N.C., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Hemp Hop, a THCa dispensary founded in Charlotte in 2018, has extended both dispensary pickup and Charlotte same day THCa delivery hours from 10 PM to 11 PM every day. [...]
Nanox.AI Optimizes Medical Imaging AI Application Framework for Intel Core Ultra Processors with OpenVINO
10/08/2026
On-premise medical imaging AI framework uses Intel Core Ultra processors and Intel ’s OpenVINO toolkit to accelerate edge inference within healthcare environments PETACH TIKVA, Israel – August 10 – Nanox AI Ltd. , a [...]
Life Biosciences Appoints Stephen Webster to Board of Directors
10/08/2026
Former Spark Therapeutics Chief Financial Officer brings deep biotech finance, commercialization, and governance expertise BOSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a clinical-stage [...]
Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
10/08/2026
JERUSALEM, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , today announced its [...]
Replimune Announces Pricing of $150 Million Underwritten Offering
10/08/2026
BOSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL) (“Replimune”), a commercial-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the [...]
Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
10/08/2026
SAN JOSE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company’s [...]
Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models
10/08/2026
Iron-Rescue Experiments Confirm Iron-Dependent Mechanism. Tumor Suppressor Gene Reactivation and Anti-Tumor and Anti-Metastatic Activity Across Multiple Models. MIAMI, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Telomir [...]
Elicio Therapeutics Announces Activation of the Investigator-Initiated Phase 1 Study of Neoadjuvant ELI-002 7P for Pancreatic Ductal Adenocarcinoma
10/08/2026
Phase 1 study conducted by Memorial Sloan Kettering (“MSK”) Cancer Center and funded by The Lustgarten Foundation Study to evaluate ELI-002 7P in combination with chemotherapy and checkpoint inhibition in the [...]
Alvotech to Report Financial Results for H1 2026
10/08/2026
REYKJAVIK, ICELAND (August 10, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, [...]
Erasca Strengthens R&D Leadership with Appointment of Internationally Recognized Medical Oncologist Charles S. Fuchs, M.D., M.P.H., as President of R&D
10/08/2026
SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/ [...]
Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader
10/08/2026
Establishes an integrated global platform spanning biosimilar R&D, manufacturing and commercialization Adds a major long-term growth pillar and extends Amneal’s growth profile into the 2030s BRIDGEWATER, N.J., Aug. [...]
Spyre Therapeutics Announces Launch of SPY772 Program and Initiation of Phase 2 SKYLIGHT Trial in Hidradenitis Suppurativa
10/08/2026
SPY772 program aims to deliver best-in-indication efficacy and convenience in Hidradenitis Suppurativa through dual inhibition of TL1A and IL-17A/F in a long-acting coformulation Phase 2 SKYLIGHT trial designed to [...]
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2026 Financial Results
10/08/2026
On track for potential approval of bezuclastinib for GIST patients (PDUFA November 30) and NonAdvSM patients (PDUFA December 30) later this year; AdvSM New Drug Application submitted to FDA on June 30 Completed [...]
Park Dental Partners, Inc. Announces Agreement to Acquire Village Family Dental Services Organization - Enters North Carolina Market
10/08/2026
The transaction is expected to add 12 practice locations and 48 doctors in North Carolina MINNEAPOLIS, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK). (the “Company”), a leading dental [...]
Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval
10/08/2026
Survival benefit is concentrated in participants with NfL biomarker response: CNM-Au8 ® -treated patients whose NfL declined or stabilized lived significantly longer than concurrently randomized controls Functional [...]
Novo Nordisk and AWS enter strategic partnership to accelerate drug discovery through AI
10/08/2026
New AI co-innovation hub in London brings together AWS engineers, AI specialists, and applied scientists alongside Novo Nordisk research and development teams to increase productivity and help reduce the time to market [...]
Alvotech to Report Financial Results for H1 2026
10/08/2026
REYKJAVIK, Iceland, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for [...]

Pages